Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The updated LPPR list for add-on reimbursement published in France

On February 18, 2021, a new List of Reimbursable Products and Services (LPPR) was published. It contains new devices included in the LPPR list in January-February 2021, as well as other modifications made during this period.

In the updated version of the LPPR, there are several newly introduced codes for medical devices.

Regarding the cardiovascular technology group,  aortic valve bioprosthesis implanted via transfemoral route PORTICO associated with installation and loading system FLEXNAV by Abbott under the code 3245340, with the reimbursement tariff of €12,132.50 was added to the LPPR list.

Regarding the diagnostic imaging technology group, guidewire for FFR measurement COMET II by Boston Scientific under the code 5208260 with the reimbursement tariff of €400 was added to the LPPR list.

Regarding the ENT technology group, a processor for cochlear or brainstem implants RONDO 3 by MED-EL under the code 3439044 with the reimbursement tariff of €6,000 was added to the LPPR list.

The new version of the LPPR list can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).